News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
474,422 Results
Type
Article (25032)
Company Profile (159)
Press Release (449224)
Multimedia
Podcasts (47)
Webinars (14)
Section
Business (123972)
Career Advice (453)
Deals (20417)
Drug Delivery (52)
Drug Development (79424)
Employer Resources (47)
FDA (12707)
Job Trends (9328)
News (233678)
Policy (18692)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (1)
Academia (1696)
Academic (1)
Accelerated approval (28)
Adcomms (29)
Allergies (136)
Alliances (33753)
ALS (172)
Alzheimer's disease (1642)
Antibody-drug conjugate (ADC) (305)
Approvals (13011)
Artificial intelligence (461)
Autoimmune disease (155)
Automation (28)
Bankruptcy (146)
Best Places to Work (8157)
BIOSECURE Act (12)
Biosimilars (133)
Biotechnology (119)
Bladder cancer (154)
Brain cancer (58)
Breast cancer (630)
Cancer (4679)
Cardiovascular disease (374)
Career advice (407)
Career pathing (20)
CAR-T (277)
CDC (11)
Celiac Disease (2)
Cell therapy (700)
Cervical cancer (36)
Clinical research (69437)
Collaboration (1480)
Company closure (3)
Compensation (858)
Complete response letters (44)
COVID-19 (2138)
CRISPR (72)
C-suite (724)
Cystic fibrosis (136)
Data (6138)
Decentralized trials (2)
Denatured (21)
Depression (135)
Diabetes (424)
Diagnostics (5417)
Digital health (37)
Diversity (11)
Diversity, equity & inclusion (18)
Drug discovery (207)
Drug pricing (47)
Drug shortages (12)
Duchenne muscular dystrophy (202)
Earnings (50352)
Editorial (26)
Employer branding (3)
Employer resources (46)
Events (77446)
Executive appointments (811)
FDA (15554)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (11)
Frontotemporal dementia (21)
Funding (1269)
Gene editing (169)
Generative AI (39)
Gene therapy (530)
GLP-1 (726)
Government (2343)
Grass and pollen (6)
Guidances (299)
Healthcare (13775)
HIV (48)
Huntington's disease (47)
IgA nephropathy (82)
Immunology and inflammation (218)
Immuno-oncology (52)
Indications (105)
Infectious disease (2352)
Inflammatory bowel disease (191)
Inflation Reduction Act (4)
Influenza (101)
Intellectual property (210)
Interviews (63)
IPO (11013)
IRA (13)
Job creations (1496)
Job search strategy (353)
JPM (30)
Kidney cancer (17)
Labor market (37)
Layoffs (326)
Leadership (17)
Legal (2299)
Liver cancer (82)
Longevity (13)
Lung cancer (631)
Lymphoma (362)
Machine learning (31)
Management (15)
Manufacturing (510)
MASH (158)
Medical device (9549)
Medtech (9592)
Mergers & acquisitions (10289)
Metabolic disorders (1025)
Multiple sclerosis (155)
NASH (14)
Neurodegenerative disease (311)
Neuropsychiatric disorders (81)
Neuroscience (2811)
Neurotech (1)
NextGen: Class of 2026 (3879)
Non-profit (2431)
Now hiring (38)
Obesity (423)
Opinion (180)
Ovarian cancer (161)
Pain (191)
Pancreatic cancer (225)
Parkinson's disease (273)
Partnered (24)
Patents (399)
Patient recruitment (507)
Peanut (53)
People (38808)
Pharmaceutical (36)
Pharmacy benefit managers (7)
Phase 1 (22365)
Phase 2 (30912)
Phase 3 (22390)
Pipeline (4858)
Policy (99)
Postmarket research (2054)
Preclinical (8060)
Press Release (28)
Prostate cancer (228)
Psychedelics (41)
Radiopharmaceuticals (273)
Rare diseases (759)
Real estate (2914)
Recruiting (19)
Regulatory (17822)
Reports (26)
Research institute (1888)
Resumes & cover letters (61)
Rett syndrome (27)
RNA editing (13)
RSV (49)
Schizophrenia (136)
Series A (224)
Series B (184)
Service/supplier (8)
Sickle cell disease (80)
Special edition (14)
Spinal muscular atrophy (151)
Sponsored (27)
Startups (2413)
State (1)
Stomach cancer (15)
Supply chain (51)
Tariffs (15)
The Weekly (26)
Vaccines (707)
Venture capital (56)
Weight loss (234)
Women's health (76)
Worklife (6)
Date
Last 7 days (514)
Last 30 days (1672)
Last 365 days (25469)
2026 (2894)
2025 (25743)
2024 (29269)
2023 (33137)
2022 (41037)
2021 (42996)
2020 (39541)
2019 (30537)
2018 (22975)
2017 (23791)
2016 (21719)
2015 (25418)
2014 (18377)
2013 (13800)
2012 (14435)
2011 (14808)
2010 (13946)
Location
Africa (374)
Alabama (73)
Alaska (3)
Arizona (175)
Arkansas (8)
Asia (29018)
Australia (5646)
California (9870)
Canada (2518)
China (1028)
Colorado (397)
Connecticut (406)
Delaware (279)
Europe (66391)
Florida (1370)
Georgia (308)
Hawaii (2)
Idaho (41)
Illinois (577)
India (43)
Indiana (405)
Iowa (17)
Japan (385)
Kansas (99)
Kentucky (33)
Louisiana (18)
Maine (27)
Maryland (1051)
Massachusetts (7020)
Michigan (200)
Minnesota (416)
Mississippi (4)
Missouri (93)
Montana (31)
Nebraska (17)
Nevada (103)
New Hampshire (64)
New Jersey (2483)
New Mexico (23)
New York (2594)
North Carolina (1216)
North Dakota (6)
Northern California (4873)
Ohio (256)
Oklahoma (20)
Oregon (36)
Pennsylvania (1905)
Puerto Rico (15)
Rhode Island (25)
South America (490)
South Carolina (43)
Southern California (3889)
Tennessee (135)
Texas (1588)
United States (33638)
Utah (263)
Vermont (1)
Virginia (216)
Washington D.C. (54)
Washington State (781)
West Virginia (2)
Wisconsin (81)
Wyoming (1)
474,422 Results for "quotient clinical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Quotient Therapeutics Appoints Seasoned Life Sciences Executive, Susan Keefe, as Chief Financial Officer
February 2, 2026
·
2 min read
Press Releases
Flagship Pioneering Announces New Agreements with ProFound Therapeutics and Quotient Therapeutics Under its Collaboration with GSK
November 21, 2025
·
5 min read
Press Releases
Quotient Therapeutics Appoints Drug Discovery and Development Veteran, Andrew Bayliffe, as Chief Development Officer
September 30, 2025
·
2 min read
Collaboration
Pfizer Partners With Flagship’s Quotient to Leverage Genetics Against Heart, Renal Diseases
Quotient Therapeutics’ platform targets somatic mutations, which the startup contends can help identify a broader scope of genes potentially associated with disease phenotypes. Wednesday’s agreement is part of an existing partnership between Pfizer and Flagship Pioneering.
August 28, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Quotient Therapeutics Appoints Sir Mene Pangalos, Ph.D. to Board of Directors
November 8, 2024
·
3 min read
Press Releases
Oragenics Targets Projected $9 Billion Market by Advancing First and Only Clinical-Stage Concussion and Mild Traumatic Brain Injury Therapy
February 9, 2026
·
8 min read
Press Releases
Siren Biotechnology to Showcase Clinical-Stage Momentum at Major 2026 Healthcare Conferences
January 8, 2026
·
2 min read
Press Releases
Quotient Therapeutics Appoints Peter Campbell, Ph.D. as Chief Scientific Officer
August 7, 2024
·
2 min read
Press Releases
TRexBio Closes $50 Million Financing to Support a Growing Clinical-Stage Immunology Pipeline of Tissue-Targeted Treg Therapeutics
January 27, 2026
·
4 min read
China
Clinical Trials Are Increasingly Going Global—With China a Main Beneficiary
AstraZeneca’s $15 billion pledge to its China operations highlights the country’s advantages. But other regions are also hoping to host more clinical studies.
February 2, 2026
·
8 min read
·
Annalee Armstrong
1 of 47,443
Next
